Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Bartek, J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 119 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Staller, P; Peukert, K; Kiermaier, A; Seoane, J; Lukas, J; Karsunky, H; Moroy, T; Bartek, J; Massague, J; Hanel, F; Eilers, M
      Repression of p15(INK4b) expression by Myc through association with Miz-1

      NATURE CELL BIOLOGY
    2. Bartek, J; Lukas, J
      p27 destruction: Cks1 pulls the trigger

      NATURE CELL BIOLOGY
    3. Bartek, J; Lukas, J
      Mammalian G1- and S-phase checkpoints in response to DNA damage

      CURRENT OPINION IN CELL BIOLOGY
    4. Bartkova, J; Falck, J; Rajpert-De Meyts, E; Skakkebaek, NE; Lukas, J; Bartek, J
      Chk2 tumour suppressor protein in human spermatogenesis and testicular germ-cell tumours

      ONCOGENE
    5. Falck, J; Lukas, C; Protopopova, M; Lukas, J; Selivanova, G; Bartek, J
      Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway

      ONCOGENE
    6. Domagala, W; Welcker, M; Chosia, M; Karbowniczek, M; Harezga, B; Bartkova, J; Bartek, J; Osborn, M
      P21/WAF1/Cip1 expression in invasive ductal breast carcinoma: relationshipto p53, proliferation rate, and survival at 5 years

      VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    7. Jensen, SS; Madsen, MW; Lukas, J; Binderup, L; Bartek, J
      Inhibitory effects of 1 alpha,25-dihydroxyvitamin D-3 on the G(1)-S phase-controlling machinery

      MOLECULAR ENDOCRINOLOGY
    8. Sorensen, CS; Lukas, C; Kramer, ER; Peters, JM; Bartek, J; Lukas, J
      A conserved cyclin-binding domain determines functional interplay between anaphase-promoting complex-Cdh1 and Cyclin A-Cdk2 during cell cycle progression

      MOLECULAR AND CELLULAR BIOLOGY
    9. Hansen, K; Farkas, T; Lukas, J; Holm, K; Ronnstrand, L; Bartek, J
      Phosphorylation-dependent and -independent functions of p130 cooperate to evoke a sustained G(1) block

      EMBO JOURNAL
    10. Bartek, J; Lukas, J
      Cell cycle - Order from destruction

      SCIENCE
    11. Bartek, J; Lukas, J
      Are all cancer genes equal?

      NATURE
    12. Falck, J; Mailand, N; Syljuasen, RG; Bartek, J; Lukas, J
      The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis

      NATURE
    13. Bartkova, J; Thullberg, M; Slezak, P; Jaramillo, E; Rubio, C; Thomassen, LH; Bartek, J
      Aberrant expression of G1-phase cell cycle regulators in flat and exophytic adenomas of the human colon

      GASTROENTEROLOGY
    14. Bartek, J; Lukas, J
      Pathways governing G1/S transition and their response to DNA damage

      FEBS LETTERS
    15. Van Keymeulen, A; Deleu, S; Bartek, J; Dumont, JE; Roger, PP
      Respective roles of carbamylcholine and cyclic adenosine monophosphate in their synergistic regulation of cell cycle in thyroid primary cultures

      ENDOCRINOLOGY
    16. Lukas, C; Bartkova, J; Latella, L; Falck, J; Mailand, N; Schroeder, T; Sehested, M; Lukas, J; Bartek, J
      DNA damage-activated kinase Chk2 is independent of proliferation or differentiation yet correlates with tissue biology

      CANCER RESEARCH
    17. Depoortere, F; Pirson, I; Bartek, J; Dumont, JE; Roger, PP
      Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1)

      MOLECULAR BIOLOGY OF THE CELL
    18. Worm, J; Bartkova, J; Kirkin, AF; Straten, PT; Zeuthen, J; Bartek, J; Guldberg, P
      Aberrant p27(Kip1) promoter methylation in malignant melanoma

      ONCOGENE
    19. Bartkova, J; Thullberg, M; Rajpert-De Meyts, E; Skakkebaek, NE; Bartek, J
      Lack of p19(INK4d) in human testicular germ-cell tumours contrasts with high expression during normal spermatogenesis

      ONCOGENE
    20. Thullberg, M; Bartek, J; Lukas, J
      Ubiquitin/proteasome-mediated degradation of p19(INK4d) determines its periodic expression during the cell cycle

      ONCOGENE
    21. Thullberg, M; Welcker, M; Bartkova, J; Kjerulff, AA; Lukas, J; Hogberg, J; Bartek, J
      Monoclonal antibody probes for p21(WAF1/CIP1) and the INK4 family of cyclin-dependent kinase inhibitors

      HYBRIDOMA
    22. Sorensen, CS; Lukas, C; Kramer, ER; Peters, JM; Bartek, J; Lukas, J
      Nonperiodic activity of the human anaphase-promoting complex-Cdh1 ubiquitin ligase results in continuous DNA synthesis uncoupled from mitosis

      MOLECULAR AND CELLULAR BIOLOGY
    23. Jones, CJ; Kipling, D; Morris, M; Hepburn, P; Skinner, J; Bounacer, A; Wyllie, FS; Ivan, M; Bartek, J; Wynford-Thomas, D; Bond, JA
      Evidence for a telomere-independent "clock" limiting RAS oncogene-driven proliferation of human thyroid epithelial cells

      MOLECULAR AND CELLULAR BIOLOGY
    24. Santoni-Rugiu, E; Falck, J; Mailand, N; Bartek, J; Lukas, J
      Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway

      MOLECULAR AND CELLULAR BIOLOGY
    25. Mailand, N; Falck, J; Lukas, C; Syljuasen, RG; Welcker, M; Bartek, J; Lukas, L
      Rapid destruction of human Cdc25A in response to DNA damage

      SCIENCE
    26. Bartkova, J; Thullberg, M; Rajpert-De Meyts, E; Skakkebaek, NE; Bartek, J
      Cell cycle regulators in testicular cancer: Loss of p18(INK4C) marks progression from carcinoma in situ to invasive germ cell tumours

      INTERNATIONAL JOURNAL OF CANCER
    27. Thullberg, M; Bartkova, J; Khan, S; Hansen, K; Ronnstrand, L; Lukas, J; Strauss, M; Bartek, J
      Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitors

      FEBS LETTERS
    28. Hlobilkova, A; Guldberg, P; Thullberg, M; Zeuthen, J; Lukas, J; Bartek, J
      Cell cycle arrest by the PTEN tumor suppressor is target cell specific andmay require protein phosphatase activity

      EXPERIMENTAL CELL RESEARCH
    29. Kosina, P; Bartek, J
      Determination of silybin in blood plasma using high performance liquid chromatography with solid phase extraction

      CHEMICKE LISTY
    30. Meraldi, P; Lukas, J; Fry, AM; Bartek, J; Nigg, EA
      Centrosome duplication in mammalian somatic cells requires E2F and Cdk2-cyclin A

      NATURE CELL BIOLOGY
    31. Van Keymeulen, A; Bartek, J; Dumont, JE; Roger, PP
      Cyclin D3 accumulation and activity integrate and rank the comitogenic pathways of thyrotropin and insulin in thyrocytes in primary culture

      ONCOGENE
    32. Lukas, J; Sorensen, CS; Lukas, C; Santoni-Rugiu, E; Bartek, J
      p16(INK4a), but not constitutively active pRb, can impose a sustained G1 arrest: molecular mechanisms and implications for oncogenesis

      ONCOGENE
    33. Lukas, C; Jensen, SS; Bartkova, J; Lukas, J; Bartek, J
      Immunochemical analysis of the D-type cyclin-dependent kinases Cdk4 and Cdk6, using a series of monoclonal antibodies

      HYBRIDOMA
    34. Petersen, BO; Lukas, J; Sorensen, CS; Bartek, J; Helin, K
      Phosphorylation of mammalian CDC6 by Cyclin A/CDK2 regulates its subcellular localization

      EMBO JOURNAL
    35. Bouchard, C; Thieke, K; Maier, A; Saffrich, R; Hanley-Hyde, J; Ansorge, W; Reed, S; Sicinski, P; Bartek, J; Eilers, M
      Direct induction of cyclin D2 by Myc contributes to cell cycle progressionand sequestration of p27

      EMBO JOURNAL
    36. Hansen, K; Lukas, J; Holm, K; Kjerulff, AA; Bartek, J
      Dissecting functions of the retinoblastoma tumor suppressor and the related pocket proteins by integrating genetic, cell biology, and electrophoretictechniques

      ELECTROPHORESIS
    37. Xu, JA; Deng, QL; Chen, JG; Houk, KN; Bartek, J; Hilvert, D; Wilson, IA
      Evolution of shape complementarity and catalytic efficiency from a primordial antibody template

      SCIENCE
    38. Bartkova, J; Rajpert-De Meyts, E; Skakkebaek, NE; Bartek, J
      D-type cyclins in adult human testis and testicular cancer: Relation to cell type, proliferation, differentiation, and malignancy

      JOURNAL OF PATHOLOGY
    39. Bartek, J; Lukas, J; Bartkova, J
      Perspective: Defects in cell cycle control and cancer

      JOURNAL OF PATHOLOGY
    40. Tanguay, D; Pavlovic, S; Piatelli, MJ; Bartek, J; Chiles, TC
      B cell antigen receptor-mediated activation of cyclin-dependent retinoblastoma protein kinases and inhibition by co-cross-linking with Fc gamma receptors

      JOURNAL OF IMMUNOLOGY
    41. Duro, D; Schulze, A; Vogt, B; Bartek, J; Mittnacht, S; Jansen-Durr, P
      Activation of cyclin A gene expression by the cyclin encoded by human herpesvirus-8

      JOURNAL OF GENERAL VIROLOGY
    42. Tanguay, DA; Colarusso, TP; Pavlovic, S; Irigoyen, M; Howard, RG; Bartek, J; Chiles, TC; Rothstein, TL
      Early induction of cyclin D2 expression in phorbol ester-responsive B-1 lymphocytes

      JOURNAL OF EXPERIMENTAL MEDICINE
    43. OSIN P; GUSTERSON BA; PHILP E; WALLER J; BARTEK J; PETO J; CROOK T
      PREDICTED ANTIESTROGEN RESISTANCE IN BRCA-ASSOCIATED FAMILIAL BREAST CANCERS

      European journal of cancer
    44. BARTKOVA J; LUKAS J; STRAUSS M; BARTEK J
      CYCLIN D3 - REQUIREMENT FOR G1 S TRANSITION AND HIGH ABUNDANCE IN QUIESCENT TISSUES SUGGEST A DUAL ROLE IN PROLIFERATION AND DIFFERENTIATION/

      Oncogene
    45. COPPEE F; DEPOORTERE F; BARTEK J; LEDENT C; PARMENTIER M; DUMONT JE
      DIFFERENTIAL PATTERNS OF CELL-CYCLE REGULATORY PROTEINS EXPRESSION INTRANSGENIC MODELS OF THYROID-TUMORS

      Oncogene
    46. MARTIN RE; BARTEK J; DIEDERICH F; TYKWINSKI RR; MEISTER EC; HILGER A; LUTHI HP
      PHOTOCHEMICAL TRANS-CIS ISOMERIZATION OF DONOR ACCEPTOR-SUBSTITUTED (E)-HEX-3-ENE-1,5-DIYNES (1,2-DIETHYNYLETHENES, DEES) AND 3,4-DIETHYNYLHEX-3-ENE-1,5-DIYNES (TETRAETHYNYLETHENES, TEES)/

      Perkin transactions. 2
    47. DEPOORTERE F; VANKEYMEULEN A; LUKAS J; COSTAGLIOLA S; BARTKOVA J; DUMONT JE; BARTEK J; ROGER PP; DREMIER S
      REQUIREMENT FOR CYCLIN D3 CYCLIN-DEPENDENT KINASE (CDK)-4 ASSEMBLY INTHE CYCLIC ADENOSINE MONOPHOSPHATE-DEPENDENT PROLIFERATION OF THYROCYTES

      The Journal of cell biology
    48. GJOERUP O; LUKAS J; BARTEK J; WILLUMSEN BM
      RAC AND CDC42 ARE POTENT STIMULATORS OF E2F-DEPENDENT TRANSCRIPTION CAPABLE OF PROMOTING RETINOBLASTOMA SUSCEPTIBILITY GENE-PRODUCT HYPERPHOSPHORYLATION

      The Journal of biological chemistry
    49. NYLANDSTED J; ROHDE M; BARTEK J; STRAUSS M
      EXPRESSION OF A P16(INK4A)-SPECIFIC RIBOZYME DOWN-MODULATES P16(INK4A) ABUNDANCE AND ACCELERATES CELL-PROLIFERATION

      FEBS letters
    50. BARTEK J; MULLER R; KOSMA P
      SYNTHESIS OF A NEOGLYCOPROTEIN CONTAINING THE LEWIS-X ANALOGOUS TRISACCHARIDE GALPNAC-(1-]4)[ALPHA-L-FUCP-(1-]3)]-BETA-D-GLCPNAC

      Carbohydrate research
    51. WELCKER M; LUKAS J; STRAUSS M; BARTEK J
      P21(WAF1 CIP2) MUTANTS DEFICIENT IN INHIBITING CYCLIN-DEPENDENT KINASES (CDKS) CAN PROMOTE ASSEMBLY OF ACTIVE CYCLIN-D CDK4(6) COMPLEXES INHUMAN TUMOR-CELLS/

      Cancer research
    52. SANDIG V; BRAND K; HERWIG S; LUKAS J; BARTEK J; STRAUSS M
      ADENOVIRALLY TRANSFERRED P6(INK4 CDKN2) AND P53 GENES COOPERATE TO INDUCE APOPTOTIC TUMOR-CELL DEATH/

      Nature medicine
    53. HAAS K; STALLER P; GEISEN C; BARTEK J; EILERS M; MOROY T
      MUTUAL REQUIREMENT OF CDK4 AND MYC IN MALIGNANT TRANSFORMATION - EVIDENCE FOR CYCLIN D1 CDK4 AND P16(INK4A) AS UPSTREAM REGULATORS OF MYC/

      Oncogene
    54. CHLUP R; VAVERKOVA H; BARTEK J
      COMPLEMENTARY INSULIN THERAPY IMPROVES BLOOD-GLUCOSE AND SERUM-LIPID PARAMETERS IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS .1. EFFECTS ON BLOOD-GLUCOSE CONTROL

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    55. VAVERKOVA H; CHLUP R; FICKER L; NOVOTNY D; BARTEK J
      COMPLEMENTARY INSULIN THERAPY IMPROVES BLOOD-GLUCOSE AND SERUM-LIPID PARAMETERS IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS .2. EFFECTS ON SERUM-LIPIDS, LIPOPROTEINS AND APOPROTEINS

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    56. BRAND K; SANDIG V; LUKAS J; BARTEK J; HERWIG S; STRAUSS M
      ADENOVIRUS-MEDIATED TRANSFER OF P16 AND P53 GENES INDUCES EFFICIENT AND SELECTIVE APOPTOTIC TUMOR-CELL DEATH

      Cancer gene therapy
    57. LUKAS J; HERZINGER T; HANSEN K; MORONI MC; RESNITZKY D; HELIN K; REED SI; BARTEK J
      CYCLIN E-INDUCED S-PHASE WITHOUT ACTIVATION OF THE PRB E2F PATHWAY/

      Genes & development
    58. JADAYEL DM; LUKAS J; NACHEVA E; BARTKOVA J; STRANKS G; DESCHOUWER PJJC; LENS D; BARTEK J; DYER MJS; KRUGER AR; CATOVSKY D
      POTENTIAL ROLE FOR CONCURRENT ABNORMALITIES OF THE CYCLIN D1, P16(CDKN2) AND P15(CDKN2B) GENES IN CERTAIN B-CELL NON-HODGKINS-LYMPHOMAS - FUNCTIONAL-STUDIES IN A CELL-LINE (GRANTA-519)

      Leukemia
    59. BACKE J; GASSEL AM; HAUBER K; KREBS S; BARTEK J; CAFFIER H; KREIPE HH; MULLERHERMELINK HK; DIETL J
      P53 PROTEIN IN ENDOMETRIAL CANCER IS RELATED TO PROLIFERATIVE ACTIVITY AND PROGNOSIS BUT NOT TO EXPRESSION OF P21 PROTEIN

      International journal of gynecological pathology
    60. MULLER H; MORONI MC; VIGO E; PETERSEN BO; BARTEK J; HELIN K
      INDUCTION OF S-PHASE ENTRY BY E2F TRANSCRIPTION FACTORS DEPENDS ON THEIR NUCLEAR-LOCALIZATION

      Molecular and cellular biology
    61. ZERFASSTHOME K; SCHULZE A; ZWERSCHKE W; VOGT B; HELIN K; BARTEK J; HENGLEIN B; JANSENDURR P
      P27(KIP1) BLOCKS CYCLIN E-DEPENDENT TRANSACTIVATION OF CYCLIN-A GENE-EXPRESSION

      Molecular and cellular biology
    62. LUKAS J; HERZINGER T; HANSEN K; RESNITZKI D; HELIN K; REED S; BARTEK J
      CYCLIN-E AND CYCLIN-D1 PROMOTE G1 S TRANSITION VIA DISTINCT MOLECULARMECHANISMS/

      European journal of cell biology
    63. HAAS K; STALLER P; GEISEN C; BARTEK J; EILERS M; MOROY T
      ONCOGENIC ACTIVITY OF CDK4 AND MYC DEPENDS ON P16(INK4A) - EVIDENCE FOR CYCLIN D1 CDK4 AND P16(INK4A) AS UPSTREAM REGULATORS OF MYC/

      European journal of cell biology
    64. ERBER R; KLEIN W; ANDL T; ENDERS C; BORN AI; CONRADT C; BARTEK J; BOSCH FX
      ABERRANT P21(CIP1 WAF1) PROTEIN ACCUMULATION IN HEAD-AND-NECK CANCER/

      International journal of cancer
    65. BARTEK J; BARTKOVA J; LUKAS J
      THE RETINOBLASTOMA PROTEIN PATHWAY IN CELL-CYCLE CONTROL AND CANCER

      Experimental cell research
    66. VAVERKOVA H; CHLUP R; NOVOTNY D; BARTEK J
      EFFECTS OF COMPLEMENTARY INSULIN THERAPY ON SERUM-LIPID, LIPOPROTEINSAND APOPROTEINS

      Diabetologia
    67. VAVERKOVA H; CHLUP R; NOVOTNY D; FICKER L; BARTEK J
      MICROALBUMINURIA, PROTEINURIA AND LIPID RISK-FACTORS IN NIDDM

      Diabetologia
    68. OTT MM; BARTKOVA J; BARTEK J; DURR A; FISCHER L; OTT G; MULLERHERMELINK HK; KREIPE H
      CYCLIN D1 EXPRESSION IN MANTLE CELL LYMPHOMA IS ACCOMPANIED BY DOWN-REGULATION OF CYCLIN D3 AND IS NOT RELATED TO THE PROLIFERATIVE ACTIVITY

      Blood
    69. POKROVSKAJA K; EHLINHENRIKSSON B; BARTKOVA J; BARTEK J; SCUDERI R; SZEKELY L; WIMAN KG; KLEIN G
      PHENOTYPE-RELATED DIFFERENCES IN THE EXPRESSION OF D-TYPE CYCLINS IN HUMAN B-CELL-DERIVED LINES

      Cell growth & differentiation
    70. BARTEK J; LUKAS J; STRAUSS M
      A COMMON-PATH TO TUMOR-GROWTH - DEREGULATION OF RB-DEPENDENT RESTRICTION POINT CONTROL (REVIEW)

      Oncology Reports
    71. SEKLJIC H; KOSMA P; BARTEK J; FUKASE K; KUSUMOTO S; BRADE H
      SYNTHESIS OF NEOGLYCOPROTEINS CONTAINING 5-O-PHOSPHORYLATED KDO-MONOSACCHARIDE, 4-O-PHOSPHORYLATED AND 5-O-PHOSPHORYLATED ALPHA-KDO-](2 6)-2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSYL DISACCHARIDE RESIDUES

      Journal of endotoxin research
    72. BARTEK J; BARTKOVA J; LUKAS J
      THE RETINOBLASTOMA PROTEIN PATHWAY AND THE RESTRICTION POINT

      Current opinion in cell biology
    73. WELCKER M; LUKAS J; STRAUSS M; BARTEK J
      ENHANCED PROTEIN STABILITY - A NOVEL MECHANISM OF D-TYPE CYCLIN OVER-ABUNDANCE IDENTIFIED IN HUMAN SARCOMA-CELLS

      Oncogene
    74. LUKAS J; PETERSEN BO; HOLM K; BARTEK J; HELIN K
      DEREGULATED EXPRESSION OF E2F FAMILY MEMBERS INDUCES S-PHASE ENTRY AND OVERCOMES P16(INK4A)-MEDIATED GROWTH SUPPRESSION

      Molecular and cellular biology
    75. LUKAS J; BARTKOVA J; BARTEK J
      CONVERGENCE OF MITOGENIC SIGNALING CASCADES FROM DIVERSE CLASSES OF RECEPTORS AT THE CYCLIN D-CYCLIN-DEPENDENT KINASE-PRB-CONTROLLED G(1) CHECKPOINT

      Molecular and cellular biology
    76. OTT MM; HELBING A; OTT G; BARTEK J; FISCHER L; DURR A; KREIPE H; MULLERHERMELINK HK
      BCL-1 REARRANGEMENT AND CYCLIN D1 PROTEIN EXPRESSION IN MANTLE CELL LYMPHOMA

      Journal of pathology
    77. RIVARD N; LALLEMAIN G; BARTEK J; POUYSSEGUR J
      ABROGATION OF P27(KIP1) BY CDNA ANTISENSE SUPPRESSES QUIESCENCE (G(0)STATE) IN FIBROBLASTS

      The Journal of biological chemistry
    78. BARTKOVA J; ZEMANOVA M; BARTEK J
      EXPRESSION OF CDK7 CAK IN NORMAL AND TUMOR-CELLS OF DIVERSE HISTOGENESIS, CELL-CYCLE POSITION AND DIFFERENTIATION/

      International journal of cancer
    79. BARTKOVA J; ZEMANOVA M; BARTEK J
      ABUNDANCE AND SUBCELLULAR-LOCALIZATION OF CYCLIN D3 IN HUMAN TUMORS

      International journal of cancer
    80. STEJSKAL D; BARTEK J; STEJSKAL P
      INSULIN-RESISTANCE IN CLINICAL-PRACTICE

      Chemicke listy
    81. STEJSKAL D; BARTEK J; MOHAPL P
      COMPUTING PROGRAM FOR EVALUATION OF DIABETES COMPENSATION AND ATHEROGENESIS RISKS

      Chemicke listy
    82. BARTKOVA J; LUKAS J; GULDBERG P; ALSNER J; KIRKIN AF; ZEUTHEN J; BARTEK J
      THE P16-CYCLIN-D CDK4-PRB PATHWAY AS A FUNCTIONAL UNIT FREQUENTLY ALTERED IN MELANOMA PATHOGENESIS

      Cancer research
    83. REED AL; CALIFANO J; CAIRNS P; WESTRA WH; JONES RM; KOCH W; AHRENDT S; EBY Y; SEWELL D; NAWROZ H; BARTEK J; SIDRANSKY D
      HIGH-FREQUENCY OF P16 (CDKN2 MTS-1/INK4A) INACTIVATION IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA/

      Cancer research
    84. PISA P; POKROVSKAJA K; PALUCKA KA; BARTEK J; WIMAN KG; SCUDERI R
      DIFFERENTIAL EXPRESSION OF CYCLIN D3 IN ACUTE VERSUS CHRONIC LYMPHOCYTIC LEUKEMIAS OF B-CELL LINEAGE

      Blood
    85. STRAUSS M; LUKAS J; BARTEK J
      UNRESTRICTED CELL CYCLING AND CANCER

      Nature medicine
    86. HAYWARD SW; DAHIYA R; CUNHA GR; BARTEK J; DESHPANDE N; NARAYAN P
      ESTABLISHMENT AND CHARACTERIZATION OF AN IMMORTALIZED BUT NONTRANSFORMED HUMAN PROSTATE EPITHELIAL-CELL LINE - BPH-1

      In vitro cellular & developmental biology. Animal
    87. BARTKOVA J; LUKAS J; STRAUSS M; BARTEK J
      CYCLIN D1 ONCOPROTEIN ABERRANTLY ACCUMULATES IN MALIGNANCIES OF DIVERSE HISTOGENESIS

      Oncogene
    88. LUKAS J; BARTKOVA J; WELCKER M; PETERSEN OW; PETERS G; STRAUSS M; BARTEK J
      CYCLIN D2 IS A MODERATELY OSCILLATING NUCLEOPROTEIN REQUIRED FOR G1 PHASE PROGRESSION IN SPECIFIC CELL-TYPES

      Oncogene
    89. STEINER P; PHILIPP A; LUKAS J; BARTEK J; EILERS M
      ACTIVATION OF MYC TRIGGERS HYPERPHOSPHORYLATION OF THE RETINOBLASTOMAPROTEIN

      Journal of cellular biochemistry
    90. DICKSON C; FANTL V; GILLETT C; BROOKES S; BARTEK J; SMITH R; FISHER C; BARNES D; PETERS G
      AMPLIFICATION OF CHROMOSOME BAND 11Q13 AND A ROLE FOR CYCLIN D1 IN HUMAN BREAST-CANCER

      Cancer letters
    91. LUKAS J; BARTKOVA J; ROHDE M; STRAUSS M; BARTEK J
      CYCLIN D1 IS DISPENSABLE FOR G(1) CONTROL IN RETINOBLASTOMA GENE-DEFICIENT CELLS INDEPENDENTLY OF CDK4 ACTIVITY

      Molecular and cellular biology
    92. STEINER P; PHILIPP A; LUKAS J; GODDENKENT D; PAGANO M; MITTNACHT S; BARTEK J; EILERS M
      IDENTIFICATION OF A MYC-DEPENDENT STEP DURING THE FORMATION OF ACTIVEG(1) CYCLIN-CDK COMPLEXES

      EMBO journal
    93. GJETTING T; LUKAS J; BARTEK J; STRAUSS M
      REGULATED EXPRESSION OF THE RETINOBLASTOMA SUSCEPTIBILITY GENE IN MAMMARY-CARCINOMA CELLS RESTORES CYCLIN D1 EXPRESSION AND G(1)-PHASE CONTROL

      Biological chemistry Hoppe-Seyler
    94. LUKAS J; PARRY D; AAGAARD L; MANN DJ; BARTKOVA J; STRAUSS M; PETERS G; BARTEK J
      RETINOBLASTOMA-PROTEIN-DEPENDENT CELL-CYCLE INHIBITION BY THE TUMOR-SUPPRESSOR P16

      Nature
    95. ANBAZHAGAN R; BARTEK J; STAMP G; PIGNATELLI M; GUSTERSON B
      EXPRESSION OF INTEGRIN SUBUNITS IN THE - HUMAN INFANT BREAST CORRELATES WITH MORPHOGENESIS AND DIFFERENTIATION

      Journal of pathology
    96. FRY AM; SCHULTZ SJ; BARTEK J; NIGG EA
      SUBSTRATE-SPECIFICITY AND CELL-CYCLE REGULATION OF THE NEK2 PROTEIN-KINASE, A POTENTIAL HUMAN HOMOLOG OF THE MITOTIC REGULATOR NIMA OF ASPERGILLUS-NIDULANS

      The Journal of biological chemistry
    97. AAGAARD L; LUKAS J; BARTKOVA J; KJERULFF AA; STRAUSS M; BARTEK J
      ABERRATIONS OF P16(INK4) AND RETINOBLASTOMA TUMOR-SUPPRESSOR GENES OCCUR IN DISTINCT SUB-SETS OF HUMAN CANCER CELL-LINES

      International journal of cancer
    98. BARTKOVA J; LUKAS J; MULLER H; STRAUSS M; GUSTERSON B; BARTEK J
      ABNORMAL PATTERNS OF D-TYPE CYCLIN EXPRESSION AND G(1) REGULATION IN HUMAN HEAD AND NECK-CANCER

      Cancer research
    99. LUKAS J; AAGAARD L; STRAUSS M; BARTEK J
      ONCOGENIC ABERRATIONS OF PL6(INK4 CDKN2) AND CYCLIN D1 COOPERATE TO DEREGULATE G(1) CONTROL/

      Cancer research
    100. DEBOER CJ; SCHUURING E; DREEF E; PETERS G; BARTEK J; KLUIN PM; VANKRIEKEN JHJM
      CYCLIN D1 PROTEIN-ANALYSIS IN THE DIAGNOSIS OF MANTLE CELL LYMPHOMA

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/10/20 alle ore 17:18:36